Found: 14
Select item for more details and to access through your institution.
Matching-Adjusted Indirect Comparison of the 52-Week Efficacy of Bimekizumab Versus Secukinumab and Ixekizumab for the Treatment of Radiographic Axial Spondyloarthritis.
- Published in:
- Rheumatology & Therapy, 2024, v. 11, n. 4, p. 1023, doi. 10.1007/s40744-024-00684-z
- By:
- Publication type:
- Article
Cost-effectiveness of romosozumab for the treatment of postmenopausal women with osteoporosis at high risk of fracture in Belgium.
- Published in:
- Osteoporosis International, 2024, v. 35, n. 7, p. 1173, doi. 10.1007/s00198-024-07043-2
- By:
- Publication type:
- Article
Comparative efficacy and safety of bimekizumab in psoriatic arthritis: a systematic literature review and network meta-analysis.
- Published in:
- Rheumatology, 2024, v. 63, n. 7, p. 1779, doi. 10.1093/rheumatology/kead705
- By:
- Publication type:
- Article
Comparative Effectiveness of Bimekizumab and Secukinumab in Patients with Psoriatic Arthritis at 52 Weeks Using a Matching-Adjusted Indirect Comparison.
- Published in:
- Rheumatology & Therapy, 2024, v. 11, n. 3, p. 817, doi. 10.1007/s40744-024-00652-7
- By:
- Publication type:
- Article
Comparative Effectiveness of Bimekizumab and Guselkumab in Patients with Psoriatic Arthritis at 52 Weeks Assessed Using a Matching-Adjusted Indirect Comparison.
- Published in:
- Rheumatology & Therapy, 2024, v. 11, n. 3, p. 829, doi. 10.1007/s40744-024-00659-0
- By:
- Publication type:
- Article
Comparative efficacy and safety of bimekizumab in axial spondyloarthritis: a systematic literature review and network meta-analysis.
- Published in:
- Rheumatology, 2024, v. 63, n. 5, p. 1195, doi. 10.1093/rheumatology/kead598
- By:
- Publication type:
- Article
Improvement in work productivity among psoriatic arthritis patients treated with biologic or targeted synthetic drugs: a systematic literature review and meta-analysis.
- Published in:
- Arthritis Research & Therapy, 2024, v. 26, p. 1, doi. 10.1186/s13075-024-03282-0
- By:
- Publication type:
- Article
Burden of Hidradenitis Suppurativa: A Systematic Literature Review of Patient Reported Outcomes.
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 1, p. 83, doi. 10.1007/s13555-023-01085-w
- By:
- Publication type:
- Article
Cost-Effectiveness of Emerging Treatments for Atopic Dermatitis: A Systematic Review.
- Published in:
- PharmacoEconomics, 2023, v. 41, n. 11, p. 1415, doi. 10.1007/s40273-023-01293-4
- By:
- Publication type:
- Article
Patient Preferences in the Management of Hidradenitis Suppurativa: Results of a Multinational Discrete Choice Experiment in Europe.
- Published in:
- Patient, 2023, v. 16, n. 2, p. 153, doi. 10.1007/s40271-022-00614-7
- By:
- Publication type:
- Article
Disease Burden and Treatment Preferences Amongst Postmenopausal Women with Severe Osteoporosis in Greece.
- Published in:
- Patient Preference & Adherence, 2023, v. 17, p. 107, doi. 10.2147/PPA.S385351
- By:
- Publication type:
- Article
Achievement of more stringent disease control is associated with reduced burden on workplace and household productivity: results from long-term certolizumab pegol treatment in patients with psoriatic arthritis.
- Published in:
- Therapeutic Advances in Musculoskeletal Disease, 2022, p. 1, doi. 10.1177/1759720X221140846
- By:
- Publication type:
- Article
Cost-effectiveness of romosozumab for the treatment of postmenopausal women at very high risk of fracture in Canada.
- Published in:
- Archives of Osteoporosis, 2022, v. 17, n. 1, p. 1, doi. 10.1007/s11657-022-01106-9
- By:
- Publication type:
- Article
Identifying Unmet Care Needs and Important Treatment Attributes in the Management of Hidradenitis Suppurativa: A Qualitative Interview Study.
- Published in:
- Patient, 2022, v. 15, n. 2, p. 207, doi. 10.1007/s40271-021-00539-7
- By:
- Publication type:
- Article